-
Something wrong with this record ?
Fractionated plasmatic separation and adsorption does not alter haemodynamic parameters in experimental acute liver failure
E. Laszikova, J. Prazak, O. Ryska, E. Koblihova, T. Tyll, M. Ryska,
Language English Country Sweden
Document type Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't
PubMed
25038598
Knihovny.cz E-resources
- MeSH
- Liver Failure, Acute physiopathology therapy MeSH
- Hemodiafiltration adverse effects instrumentation methods MeSH
- Hemodynamics physiology MeSH
- Disease Models, Animal MeSH
- Swine MeSH
- Animals MeSH
- Check Tag
- Animals MeSH
- Publication type
- Journal Article MeSH
- Clinical Trial MeSH
- Research Support, Non-U.S. Gov't MeSH
OBJECTIVE: Acute liver failure (ALF) is a rare disease with a bad prognosis. Its start is accompanied by haemodynamic instability. The aim of our study was to evaluate the influence of fractionated plasmatic separation and adsorption (FPSA) on body haemodynamics using a large animal experimental model of ALF. METHODS: ALF was induced by the devascularisation of 21 laboratory pigs. FPSA was applied in 14 animals and seven animals formed a control group. Values of systemic vascular resistance index (SVRI), heart rate (HR), pulmonary artery wedge pressure (PAWP) and cardiac index (CI) at hours 3, 6, 9 and 12 of the experiment were compared. The values from laboratory tests conducted with FPSA-treated vs. untreated ALF animals were compared using Student's t-test, paired or unpaired, as required, and Mann-Whitney U-test using EXCEL and QUATRO spreadsheet applications. RESULTS: We found no significant differences in mean arterial pressure, SVRI, or plasma lactate (p>0.05) in the FPSA-treated group but there was a significant decrease(p<0.05) in intracranial pressure (ICP). Furthermore, we observed a significant decrease in HR at hour 3. A significant increase in CI at hour 9 and a significant decrease in pulmonary artery wedge pressure at hours 6 and 12 were also observed. CONCLUSION: Our study of FPSA application (Prometheus device) for treatment of experimental ALF in a large animal model did not confirm the earlier reported development of changes in body haemodynamics.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14074124
- 003
- CZ-PrNML
- 005
- 20141006124835.0
- 007
- ta
- 008
- 141006s2014 sw f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)25038598
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sw
- 100 1_
- $a Laszikova, Eva $u Department of Anaesthesiology, Resuscitation, and Intensive Care, 1st Faculty of Medicine and General Faculty Hospital, Charles University, Prague, Czech Republic.
- 245 10
- $a Fractionated plasmatic separation and adsorption does not alter haemodynamic parameters in experimental acute liver failure / $c E. Laszikova, J. Prazak, O. Ryska, E. Koblihova, T. Tyll, M. Ryska,
- 520 9_
- $a OBJECTIVE: Acute liver failure (ALF) is a rare disease with a bad prognosis. Its start is accompanied by haemodynamic instability. The aim of our study was to evaluate the influence of fractionated plasmatic separation and adsorption (FPSA) on body haemodynamics using a large animal experimental model of ALF. METHODS: ALF was induced by the devascularisation of 21 laboratory pigs. FPSA was applied in 14 animals and seven animals formed a control group. Values of systemic vascular resistance index (SVRI), heart rate (HR), pulmonary artery wedge pressure (PAWP) and cardiac index (CI) at hours 3, 6, 9 and 12 of the experiment were compared. The values from laboratory tests conducted with FPSA-treated vs. untreated ALF animals were compared using Student's t-test, paired or unpaired, as required, and Mann-Whitney U-test using EXCEL and QUATRO spreadsheet applications. RESULTS: We found no significant differences in mean arterial pressure, SVRI, or plasma lactate (p>0.05) in the FPSA-treated group but there was a significant decrease(p<0.05) in intracranial pressure (ICP). Furthermore, we observed a significant decrease in HR at hour 3. A significant increase in CI at hour 9 and a significant decrease in pulmonary artery wedge pressure at hours 6 and 12 were also observed. CONCLUSION: Our study of FPSA application (Prometheus device) for treatment of experimental ALF in a large animal model did not confirm the earlier reported development of changes in body haemodynamics.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a hemodiafiltrace $x škodlivé účinky $x přístrojové vybavení $x metody $7 D017583
- 650 _2
- $a hemodynamika $x fyziologie $7 D006439
- 650 _2
- $a akutní selhání jater $x patofyziologie $x terapie $7 D017114
- 650 _2
- $a prasata $7 D013552
- 655 _2
- $a klinické zkoušky $7 D016430
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Prazak, Josef $u Anaesthesiology, Resuscitation and Intensive Care Clinic, 2nd Faculty of Medicine, Charles University, Prague, Czech Republic.
- 700 1_
- $a Ryska, Ondrej $u Department of Surgery, 2nd Faculty of Medicine, Charles University and Central Military Hospital, Prague, Czech Republic.
- 700 1_
- $a Koblihova, Eva $u Department of Surgery, 2nd Faculty of Medicine, Charles University and Central Military Hospital, Prague, Czech Republic.
- 700 1_
- $a Tyll, Tomas $u Department of Anaesthesiology, Resuscitation, and Intensive Care, 1st Faculty of Medicine and General Faculty Hospital, Charles University, Prague, Czech Republic.
- 700 1_
- $a Ryska, Miroslav $u Department of Surgery, 2nd Faculty of Medicine, Charles University and Central Military Hospital, Prague, Czech Republic.
- 773 0_
- $w MED00168352 $t Neuro endocrinology letters $x 0172-780X $g Roč. 35, č. 4 (2014), s. 280-4
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25038598 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20141006 $b ABA008
- 991 __
- $a 20141006125312 $b ABA008
- 999 __
- $a ok $b bmc $g 1042007 $s 873036
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 35 $c 4 $d 280-4 $i 0172-780X $m Neuro-endocrinology letters $n Neuro-endocrinol. lett. $x MED00168352
- LZP __
- $a Pubmed-20141006